Skip to content

Development and Feasibility Testing of a Mobile Phone-Based HIV Primary Care Engagement Intervention

Development and Feasibility Testing of a Mobile Phone-Based HIV Primary Care Engagement Intervention

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02468544
Enrollment
0
Registered
2015-06-11
Start date
2017-03-31
Completion date
2017-04-30
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adherence, HIV

Keywords

Engagement in care, mHealth

Brief summary

This is an open-trial pilot study in which adult methadone maintenance treatment patients who are living with HIV but are not engaged in HIV primary care (i.e., missed appointments, non-adherence to medication) will be recruited to participate in a HIV primary care engagement study. The purpose of this study is to develop and test the feasibility and acceptability of a mobile phone-based health (mHealth) text messaging intervention to improve engagement in HIV primary care among substance abusing populations with HIV.

Interventions

OTHERText messaging

Text messaging mHealth intervention to improve HIV Primary Care Engagement among clients of methadone maintenance treatment programs who are living with HIV.

Sponsors

Columbia University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Client of a methadone maintenance treatment program * HIV positive (status confirmed by medical records) * At least 18 years of age * English speaking * Comfortable using a mobile phone (to send and receive text messages) * Lives in New York City * Willingness to attend at least two design sessions * Willingness to attend one usability testing session, and participate in a post-usability survey and exit interview.

Design outcomes

Primary

MeasureTime frameDescription
Acceptability of Intervention30 daysAcceptability of the intervention will be measured using the Technology Acceptance Model (TAM) scale.
Feasibility of Intervention30 daysFeasibility of the intervention will be assessed focusing on study implementation, including recruitment and attrition rates.

Secondary

MeasureTime frameDescription
Efficacy of the intervention30 daysPreliminary efficacy of the intervention will be measured using the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES) and the HIV appointment adherence questionnaire.

Other

MeasureTime frameDescription
Self-efficacy to self-manage HIV infection30 daysChanges in self-efficacy to self-manage HIV infection will be measured using the self-management scale applied to persons with HIV/AIDS.
Improvements in HIV knowledge30 daysImprovements in HIV knowledge will be measured by changes in HIV knowledge. We will use the HIV Knowledge Questionnaire (HIV-KQ-18) at baseline and at 30 days post baseline assessments to measure changes in HIV knowledge.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026